Osteoporosis associated with excess glucocorticoids.

Joseph L Shaker, Barbara P Lukert

Journal: Endocrinology and metabolism clinics of North America 2005;34(2):341-56, viii-ix

PMID: 15850846

Abstract

Excess glucocorticoids, whether endogenous or exogenous, can cause osteoporosis and fractures. Even low doses of oral glucocorticoids and mild endogenous hypercortisolism may be associated with bone loss. Patients treated with glucocorticoids, however, often are not evaluated and treated for this problem. Patients on chronic glucocorticoids or initiating these drugs should have their bone density measured and appropriate laboratory studies. They should be treated with adequate calcium and vitamin D, and antiresorptive therapy (particularly bisphosphonates) should be considered.

Address: Endocrine-Diabetes Center, St. Luke's Medical Center, University of Wisconsin School of Medicine, 2801 West KK River Parkway, Suite 245, Milwaukee, WI 53215, USA. [email protected]
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.